Healthcare is the most critical element of an emerging economy. Working with leading players allows me to contribute in shaping the industry to achieve improved outcomes for the community.
Ujwal provides mergers and acquisitions (M&A) and growth equity advisory services to clients in the healthcare sector. He identifies private equity groups and high growth companies seeking growth capital targets for clients and manages communication with clients, investors and buyers.
Ujwal has led transaction execution for several companies in the healthcare sector, which include healthcare services, hospitals, out-of-hospital care, home care, pharma and medical devices.
Prior to joining Lincoln, Ujwal worked as an associate at a boutique advisory firm in Mumbai, where he focused on healthcare delivery transactions.
Ujwal earned a Master of Business Administration from Bombay University and a Bachelor of Engineering from Pune University.
Recent Transactions in India
Lincoln International advised on the sale of Nova IVI, India’s second largest provider of fertility treatment services, to TPG Growth
Lincoln International represents PeopleStrong in a control deal transaction with Multiples Private Equity
Lincoln International represents Alchemy Special Opportunities in the sale of Zircosil to Trebol, Torrecid, Endeka, Matrix Guangzhu Chemicals Corporation
Lincoln International represents SUEZ SA in its acquisition of Driplex Water Engineering Ltd.
Lincoln International advised Vivimed Labs Limited (BSE:532660) on its sale of its Specialty Chemicals Portfolio to Clariant (India) Ltd.